GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Capex-to-Revenue

Lombard Medical Technologies (LSE:LMT) Capex-to-Revenue : 0.04 (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Lombard Medical Technologies's Capital Expenditure for the six months ended in Dec. 2012 was £-0.14 Mil. Its Revenue for the six months ended in Dec. 2012 was £3.89 Mil.

Hence, Lombard Medical Technologies's Capex-to-Revenue for the six months ended in Dec. 2012 was 0.04.


Lombard Medical Technologies Capex-to-Revenue Historical Data

The historical data trend for Lombard Medical Technologies's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Capex-to-Revenue Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.01 0.03 0.13 0.04

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.01 0.03 0.13 0.04

Competitive Comparison of Lombard Medical Technologies's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's Capex-to-Revenue falls into.



Lombard Medical Technologies Capex-to-Revenue Calculation

Lombard Medical Technologies's Capex-to-Revenue for the fiscal year that ended in Dec. 2012 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.137) / 3.89
=0.04

Lombard Medical Technologies's Capex-to-Revenue for the quarter that ended in Dec. 2012 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.137) / 3.89
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies  (LSE:LMT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Lombard Medical Technologies Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.